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ABSTRACT
Objectives: To understand the worldwide scope of RBC cross-
matching and issuing practices and measure efficiency using
a novel quality indicator, the crossmatch/issue (C/I) ratio.
Methods: An electronic survey was disseminated to hospital
transfusion services collecting details about RBC cross-
matching and issuing practices. Respondents were asked to
enumerate the number of RBCs crossmatched and issued at
their institutions during the 2014 calendar year to calculate
the C/I ratio.
Results: Fifty-two survey responses were received, mostly
from North American transfusion services (28/52, 54%). The
electronic crossmatch was the most common technique
(n¼ 29), and most respondents performed the crossmatch at
the time that an order for RBCs was received in the transfu-
sion service (even if an order to issue the RBCs was not
received). Data to calculate the C/I ratio were supplied by 22
respondents, and the mean6 SD was 1.306 0.34. There was
no difference in C/I ratios between services that use the elec-
tronic or serologic crossmatch techniques (P¼ .49). The ratio
was the same at the four sites that crossmatch RBCs at the
time of issue compared with the time of order receipt (mean
6 SD, 1.116 0.09 vs. 1.356 0.36, respectively; P¼ .19).
Conclusions: Electronic crossmatching is common, and the
C/I ratio can be an indicator of efficiency.
Hospital transfusion services are always searching for
ways to improve efficiency. A major advancement in effi-
ciency is the use of the electronic crossmatch (EXM); this
is an electronic system whereby patients with a valid type
and screen who lack active or historical antibodies can
have RBC units crossmatched for them using a computer
that has logic to permit the issue of a unit that is ABO com-
patible and prevent the issue of one that is incompatible.
As this crossmatch technique is performed entirely elec-
tronically, it can be completed in minutes. With the sero-
logic safety of the EXM now well established,1-3 the
question becomes when should RBCs for patients be
Upon completion of this activity you will be able to:
• calculate the crossmatch/issue (C/I) ratio.
• explain how the C/I ratio is useful in determining the optimal time for
crossmatching RBC units.
• outline an approach to use C/I to optimize blood bank efficiency.
The ASCP is accredited by the Accreditation Council for Continuing
Medical Education to provide continuing medical education for physicians.
The ASCP designates this journal-based CME activity for a maximum of 1
AMA PRA Category 1 CreditTM per article. Physicians should claim only the
credit commensurate with the extent of their participation in the activity.
This activity qualifies as an American Board of Pathology Maintenance of
Certification Part II Self-Assessment Module.
The authors of this article and the planning committee members and
staff have no relevant financial relationships with commercial interests
to disclose.
Exam is located at www.ascp.org/ajcpcme.
C
M
E/
S
A
M
238 Am J Clin Pathol 2016;146:238-243
DOI: 10.1093/ajcp/aqw107
© American Society for Clinical Pathology, 2016. All rights reserved.
For permissions, please e-mail: journals.permissions@oup.com
AJCP / ORIGINAL ARTICLE
Downloaded from https://academic.oup.com/ajcp/article-abstract/146/2/238/1731577
by Danish Regions user
on 11 December 2017
crossmatched. Many transfusion services, apprehensive of
causing delays in supplying crossmatched RBCs, perform
the EXM as soon as an order for RBCs is received on a pa-
tient, even if the order does not specify when the RBCs
will be requested for transfusion. These crossmatched units
are thus designated for that particular recipient and remain
in the transfusion service’s inventory until another order is
received to actually issue them. Thus, these units are ef-
fectively not available for use in other patients in anticipa-
tion of them being issued for a specific recipient. Other
transfusion services wait until an order to issue the RBCs is
received and then perform the crossmatch as part of the
issuing process. This crossmatching policy should opti-
mize the fluidity of the transfusion service’s inventory as
RBCs are not designated for a specific recipient until an
order to issue them is received. Transfusion services that
routinely use the serologic crossmatch (SXM), whereby
the potential RBC donor’s cells are physically mixed with
the recipient’s plasma or when RBCs are ordered on pa-
tients who do not qualify for the EXM, most likely do not
wait until an order to issue RBCs has been received before
performing the crossmatch due to the extra time required
to prepare and perform the SXM.
A novel method of measuring crossmatching effi-
ciency is the crossmatch/issue (C/I) ratio. Proposed by Lin
et al,4 the C/I ratio is a metric of how often a crossmatched
unit is actually issued. Thus, it is a measure of how effi-
ciently the RBC inventory is managed within the transfu-
sion service. This ratio is independent of whether the unit
is transfused, wasted, or returned as these events are out of
the control of the transfusion service once the RBC has
been issued. A low C/I ratio is desirable and indicates that
the transfusion service’s RBC inventory is not assigned un-
necessarily to patients on whom RBCs are ultimately not
issued. The C/I ratio, as a measure of efficiency, is analo-
gous to the crossmatch/transfusion (C/T) ratio by which
clinical services’ RBC ordering practices are evaluated.5 In
their study, Lin et al4 demonstrated that when their transfu-
sion service changed their crossmatch timing policy for
EXM-eligible patients from being performed when the
RBCs were ordered to when they were actually issued, the
adjusted median turnaround time for RBC issuing was a
clinically insignificant (albeit statistically significant)
1minute longer, and their C/I ratio decreased from 1.15 to
1.0 as expected.
To better understand the current trends in hospital trans-
fusion service RBC crossmatching and issuing policies, the
Biomedical Excellence for Safer Transfusion (BEST)
Collaborative undertook an international survey of these
practices and collected C/I data to determine if there is an
ideal timing and method of performing RBC crossmatches
that optimizes this novel quality indicator.
Materials and Methods
RBC Crossmatching and Issuing Survey
A working party comprising BEST members designed
a web-based (REDCap software) survey that collected basic
hospital demographic information, along with details about
how and when RBCs are crossmatched and issued, as well
as how RBCs are distributed from the transfusion service to
patient areas throughout the hospital for transfusion. The
survey was initially piloted using selected BEST members
from around the world who provided feedback on the flow
of the survey, its comprehensibility, and nature of the ques-
tions posed. After refining the survey based on this feed-
back, the survey link was electronically distributed to the
entire BEST membership. Members were encouraged to
send the link to other hospital-based colleagues who could
contribute data. The survey link became active on January
1, 2015, and remained open for approximately 1 year.
C/I Data Collection and Calculation
Data were retrospectively collected for the 2014 calen-
dar year. A list of all crossmatched RBCs that were issued
was obtained, representing all crossmatches that had been
performed during 2014. From this list, the following cross-
matches were excluded:
1. Serologically crossmatched units for patients with active
or historical antibodies (even if the main crossmatch
technique was the serologic crossmatch)
2. RBC units that were issued to hospital wards where a
different crossmatch policy was applied relative to the
rest of the hospital
3. Uncrossmatched RBCs issued from remote refrigerators
in emergencies (since they were crossmatched at a time
following their issue)
4. Crossmatches that were, for any reason, not performed
using the routine crossmatching technique (such as pa-
tients with an ABO discrepancy whose RBCs were
crossmatched using the immediate spin technique at a
center that routinely used the electronic crossmatch)
The number of study-eligible crossmatches was thus the
number of crossmatches performed during 2014, after these
exclusions had been subtracted. From the list of study-eli-
gible crossmatches, the number of crossmatched RBCs that
were issued was determined. The C/I ratio was calculated
by dividing the number of study-eligible crossmatches by
the number of issued RBCs.
Descriptive statistics and the Mann-Whitney test were
performed using Prism version 6 (GraphPad Software, San
Diego, CA). Appropriate ethics board approvals were ob-
tained at all participating institutions.
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Results
RBC Crossmatching and Issuing Survey
There were 52 usable survey replies received. Most
replies (28/52, 54%) were from transfusion services in
North America, followed by 15 (29%) of 52 responses from
Europe, six (12%) of 52 from Asia, two (4%) of 52 from
South America, and one (2%) of 52 from the Middle East
(Israel). Most hospitals (17/52, 33%) issued between 5,001
and 10,000 RBCs per year, while 15 (20%) of 52 issued be-
tween 10,001 and 20,000 RBCs per year, and 13 (25%) of
52 issuedmore than 20,000 per year. For seven (13%) of 52
respondents, the transfusion services issued fewer than
1,001 RBCs per year. The type of hospital from which these
52 transfusion services responded is shown in Figure 1 .
Fifty of 52 respondents reported the nature of their main
(ie, performed50% of the time) technique for performing
the crossmatch. The EXMwas the main crossmatch technique
for 29 (58%) of 50 respondents, followed by the immediate
spin serologic crossmatch (13/50, 26%) and the antiglobulin
serologic crossmatch (8/50, 16%). A variety of different sero-
logic crossmatch techniques was performed at these respond-
ents’ transfusion services, even if it was not their main
crossmatching method, as demonstrated in Figure 2 .
Among the 49 of 52 respondents who indicated when
they actually performed the crossmatch, the number was
similar between those who crossmatched RBCs at the time
that an order for RBCs was received in the transfusion ser-
vice (even if an order to issue the RBCs was not yet
received) (25/49, 51%) and those who performed the cross-
match at the time the RBCs were issued (20/49, 41%). Four
(8%) of 49 respondents either did not perform any form of
crossmatch if the antibody screen was negative or per-
formed the crossmatch at different times depending on the
patient’s clinical situation.
Many sites reported using combinations of methods
for distributing RBCs, such as having RBCs picked up by
the clinical ward staff, delivered by transfusion service
personnel, and/or the use of pneumatic tube or blood lift.
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Figure 1 Hospital types of the respondents to the RBC crossmatching and issuing survey.
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Figure 2 Serologic crossmatch techniques employed by
the respondents to the RBC crossmatching and issuing sur-
vey. The total number of replies exceeds 50 because re-
spondents were asked to report all crossmatching
techniques employed in their transfusion service, not just
their main technique. LISS, low ionic strength saline;
PEG, polyethylene glycol.
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Forty-seven of 52 sites reported their percentages of use for
these different distribution methods; the main (ie,
used>50% of the time) single method of distributing RBCs
to patient wards was by having nontransfusion service per-
sonnel pick up the units (29/47, 62%), followed by delivery
of the RBCs by a pneumatic tube (11/47, 23%) and delivery
of the RBCs to wards by transfusion service personnel
(6/47, 13%). One (2%) site reported using a pneumatic tube
and pickup by nontransfusion service staff equally.
Of the 52 respondents, 49 supplied the timing for when
RBCs were considered “issued” by the transfusion service.
The survey offered three timing options: (1) when RBCs are
packed in a cooler, picked up, or placed in a pneumatic tube
or blood lift; (2) at the time that the crossmatch is performed
(regardless of whether it is issued immediately after cross-
matching); and (3) at the time the RBCs arrive at a patient
ward. Many different combinations of timings were
observed. Figure 3 demonstrates the number of times that
a respondent indicated that at least one of those timing op-
tions described their transfusion service’s RBC issue time.
Note that the total number of replies exceeds 49 because in
many cases, combinations of issue timing options were
reported.
C/I Data Collection and Calculation
Twenty-two respondents submitted data on the number
of crossmatches performed and RBCs issued in 2014. Most
of these hospitals (16/22, 73%) were from the United States,
while three (14%) were from Asia, two (9%) were from
Europe, and one (5%) was from South America. The type of
hospital, number of beds, and their calculated C/I ratios are
shown in Figure 4 . The mean 6 SD C/I ratio for these 22
hospitals was 1.306 0.34 (dashed horizontal line in Figure
4). Fifteen of these transfusion services performed EXM as
their main crossmatch technique, and their mean 6 SD C/I
ratio was 1.236 0.19; the remaining seven hospitals per-
formed the SXM as their main crossmatch technique, and
their mean6SD C/I ratio was 1.466 0.53 (P¼ .49).
Eighteen transfusion services performed the crossmatch at
the time of receipt of the RBC order, and their mean 6 SD
C/I ratio was 1.356 0.36; the remaining four transfusion
services performed the crossmatch at the time of RBC issue,
and their mean6 SD C/I ratio was 1.116 0.09 (P¼ .19). At
one of these four sites, the C/I ratio was 1.0; the mean6 SD
C/I ratio at the other three sites was 1.146 0.06 (Figure 4).
Discussion
This survey revealed the widespread use of the EXM
throughout the world, although the SXM is still commonly
employed as the main crossmatch method. Furthermore,
there is a fairly even divide between when RBC units are
crossmatched (at the time of order receipt vs at the time of
issue). While the numbers were small, these results suggest
that perhaps the transfusion service might operate more effi-
ciently if the crossmatch was performed at the time that
RBCs are being issued.
The C/I ratio could be a useful transfusion service qual-
ity indicator, since it reflects how often a crossmatch is per-
formed compared with how many RBCs are actually issued.
Interestingly, among the four sites in this study that reported
performing the crossmatch at the time the RBCs are issued,
one site uses the SXM as its main method. This indicates
that it is not essential to use the EXM for time of issue cross-
matching, although the extra time required to perform the
SXM must be factored into the clinical decision making
when placing an RBC order. Furthermore, among these four
sites, only one had a C/I ratio of 1.0. The most likely explan-
ations for not having a 1.0 ratio at the other three sites in-
clude the possibility that some of the RBCs were
crossmatched before the time of issue and were subse-
quently not issued or that an order to issue the RBCs had
been received in the transfusion service and the RBCs
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crossmatched, but the patient’s condition had rapidly
changed such that the RBCs were not actually issued.
Although there was perhaps only a trend toward signifi-
cance due to the small sample size, the mean C/I ratio of the
four sites that perform the crossmatch at the time of issue
appeared to be lower than that of the other 18 sites that
crossmatch RBCs at the time the order is received. It should
be noted that two sites that crossmatch RBCs at the time
that an RBC order is received had C/I ratios of 1.0. Overall,
though, these data suggest that the time of issue might be a
more efficient time to perform the crossmatch.
That the C/I ratio for the sites that performed the cross-
match at the time of issue was not always 1.0 suggests that
this figure (1.0) is too stringent a benchmark and that some
leeway should be allowed if the C/I ratio is to be used as a
quality indicator, given the fluid nature of the recipients’
clinical conditions and/or changes in the timing of pro-
cedures (much the same way that a C/T ratio of 1.0 is un-
realistic). Thus, perhaps the benchmark figure for the C/I
ratio should be considered less than 1.15 to both optimize
inventory management and account for changing clinical
situations.
This study has some limitations. The main limitation is
the relatively small number of respondents who provided
data to calculate the C/I ratio, especially for those sites that
perform the crossmatch at the time of issue. A larger sam-
ple size would have permitted a more accurate assessment
of any statistical difference in C/I ratio between sites that
perform the crossmatch at different times. However, even
with this small sample size, a lower mean C/I ratio was
appreciated among the sites that perform the crossmatch at
the time of issue, as expected. As with any survey, it is also
possible that some questions were misinterpreted or misun-
derstood, which could have led to some respondents pro-
viding incorrect answers or not providing RBC crossmatch
and issue data in accord with the study protocol. This latter
possibility seems unlikely given the relatively small stand-
ard deviation for the overall C/I ratio for the 22 sites that re-
ported C/I data. Thus, the statistical analysis presented in
this article must be interpreted with caution; it is provided
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Figure 4 Crossmatch/issue (C/I) ratios for the 20 transfusion services that supplied data. The dotted horizontal line indicates
the mean of the individual C/I ratios, 1.30. The gray bars represent transfusion services that perform the crossmatch at the
time of issue, and the black bars represent transfusion services that perform the crossmatch at the time of RBC order receipt.
CTS, centralized transfusion service.
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to give the reader a sense of the differences between the
groups. With a larger sample size, different trends might
become apparent.
The C/I ratio can be used to measure the efficiency of
different crossmatching techniques and the time at which
the crossmatch is performed. A larger study will be required
to definitively establish the benchmark value for this quality
indicator, but these data suggest that a C/I ratio of less than
1.15 is achievable from both clinical and inventory manage-
ment perspectives.
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